Loading clinical trials...
Loading clinical trials...
A Phase I Study of BAFF CAR-T Cells (LMY-920) for Treatment of Systemic Lupus Erythematosus
Conditions
Interventions
LMY-920
Locations
1
United States
Nationwide Children's
Columbus, Ohio, United States
Start Date
April 1, 2025
Primary Completion Date
April 15, 2026
Completion Date
June 15, 2026
Last Updated
June 3, 2025
NCT07526350
NCT06875960
NCT06335979
NCT06647069
NCT07371468
NCT06133972
Lead Sponsor
Luminary Therapeutics
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions